PPP1R14B and liver cancer: PHI-1 expression also positively correlates with the presence of myeloid-derived suppressor cells (MDSCs) in breast and liver cancers [36], suggesting that PHI-1 contributes to immune evasion mechanisms that may impact the efficacy of immunotherapies.